This news was first originally published in Hindustan Times. You can read the original source here.
Recently 529 media professionals have been screened for Covid-19 and out of them, only 3 have been tested positive for the virus. The chief minister of Delhi Arvind Kejriwal shared his happiness by his tweet, “I am so happy to share only 3 out of 529 media persons tested have been detected positive. My best wishes to all of you. Your work is very important esp during a pandemic. Those who have been detected positive, I am praying for your speedy recovery”
A special Covid-19 center was set up last week to test media professionals who have been reporting from the field during the lockdown. These professionals risk their lives to provide live news coverage to keep everyone updated. Although the central government issued an advisory for media professionals working in the print and electronic sector of the industry the test was necessary to screen out whether they are safe from coronavirus pandemic or not. The media reporters and team have been advised to take health and related precautions while performing their duties.
53 media professionals were tested positive in Mumbai after that chief minister Arvind Kejriwal said that we will get coronavirus test of media professionals in Delhi. It’s need of the hour. Media is one of the most essential services which have to remain functional during the nationwide lockdown. Those who are involved in this essential service have got curfew passes to work effectively in the frontline to fight against the coronavirus.
Corona Vaccine Researches
The mysterious coronavirus outbreak in the Chinese city Wuhan, now termed as COVID-19, and its fast spread to many other countries, endangers thousands of lives. Believed to have transmitted from animals and reptiles such as snakes, coronaviruses cause respiratory issues such as upper respiratory tract illnesses and lower respiratory illnesses such as pneumonia and bronchitis. The pandemic has catalyzed the development of novel coronavirus vaccines across the biotech industry, both by pharmaceutical companies and research organizations such as the National Institutes of Health US.
The good news is, we know where to look, and which strategies are most likely to work. At least 60 different compounds are now being investigated, including existing drugs and therapies being designed from scratch, and in record time.
Pharmaceutical giants Sanofi and GSK have teamed up to develop a vaccine. Australian scientists have begun injecting ferrets with two potential vaccines. It is the first comprehensive pre-clinical trial involving animals, and the researchers hope to test humans by the end.
The first human trial for a vaccine was announced last month by scientists in Seattle. Unusually, they are skipping any animal research to test its safety or effectiveness. In Oxford, the first human trial in Europe has started with more than 800 recruits – half will receive the COVID 19 vaccine and the rest a control vaccine that protects against meningitis but not coronavirus.